Search All News
Dr. Hershman will begin her six-year term as co-chair in the Spring of 2025.
The award recognizes Dr. Dalla-Favera's over 40-year career working to advance scientific understanding of lymphoma and cancer genetics.
Tannishtha Reya, PhD, is establishing the new Irving Cancer Drug Discovery Program, devoted to helping faculty accelerate research discoveries in their labs to the clinic.
The awardees are proposing innovative clinical trials that aim to advance treatment and interventions for multiple areas of health and medicine.
- February 13, 2023
HICCC Director Anil Rustgi, MD, is being honored for his major contributions in advancing the care of patients with digestive diseases through clinical or translational research.
- February 2, 2023
President Joe Biden announced his intent to appoint six experts to the National Cancer Advisory Board.
- January 9, 2023
Translational scientist Robert Wechsler-Reya, PhD, an expert in pediatric brain cancer, has joined the Herbert Irving Comprehensive Cancer Center as scientific director of Brain Tumor Research.
Source:CUIMC NewsroomOctober 17, 2022
Dr. Ghosh has been elected to the National Academy of Medicine for pioneering studies of NF-kB and establishing strategies to target NF-kB in the treating inflammatory diseases and cancer.
- September 1, 2022
Congratulations to Lauren Houghton, Chin Hur, Markus D. Siegelin, and Neil Vasan, the new Class of Velocity Fellows, for their innovative, life-changing cancer research.
- August 25, 2022
Ten Columbia research teams have received a Life Science Accelerator Pilot Grant for their novel, out-of-the-box ideas for translational research.
- July 12, 2022
Annual Precision Medicine Pilot Grants are awarded to five Columbia research teams, including research led by members Drs. Brent Stockwell and Kelley Yan.
- June 30, 2022
Three multi-disciplinary research teams have been awarded the 2022 Irving Multi-PI Planning Grant to fuel innovative research and treatment.
- June 27, 2022
A multi-institution team of lung cancer experts have received a new SU2C grant to bring technology-enabled immunotherapy monitoring to under-represented patients.
- May 23, 2022
The American Society of Clinical Oncology (ASCO) and Conquer Cancer Foundation have recognized seven leading oncology trainees from Columbia Cancer with Young Investigator Awards and Merit Awards.